Anthoula Lazaris

Company: RI-MUHC Liver Disease Biobank

Job title: Scientific Director

Seminars:

Enhancing Colorectal Cancer Care: Cost-Benefit of ctDNA Monitoring for Wider Adoption 2:10 pm

How does post-surgery ctDNA detection predict recurrence and support timely intervention in CRCLM patients? What are the cost-saving benefits of using affordable digital PCR panels over traditional sequencing methods? How can treatment adjustment based on ctDNA status reduce over-treatment, improve patient quality of life, and promote adoption in healthcare systems?Read more

day: Day Two Track B (PM)

DEI Panel: Forging Pathways to Equitable Precision Medicine by Ensuring Universal Access to Liquid Biopsies & MRD Detection 12:30 pm

Discussing how liquid biopsies can reduce disparities in early cancer detection and monitoring, improving outcomes for underserved and underrepresented communities globally Evaluating how current strategies are working to ensure equal access to liquid biopsies and MRD detection, regardless of socioeconomic status Analysing the impact of MRD as an objective measure, irrespective of gender or ethnicity,…Read more

day: Day One AM